PAREA gGmbH
PAREA is a non-profit, membership-based, and multidisciplinary alliance committed to the safe, ethically responsible, and accessible integration of psychedelic-assisted therapies into European healthcare[2]. The initiative brings together a wide range of stakeholders, including patient associations, medical professional societies, scientific associations, umbrella organizations, psychedelic foundations, and representatives from the private sector[1][2].
Key Products and Services
PAREA itself does not develop pharmaceutical products but focuses on pooling the knowledge, experience, and expertise of various actors. The goal is to provide evidence-based information, guidelines, and recommendations for policymakers, healthcare providers, and the public. The focus is on scientific support, the promotion of research, and the development of adequate regulatory frameworks for psychedelic-assisted therapies[2][4].
Mission and Values
The main mission of PAREA is the safe, modern, and ethically responsible integration of psychedelic-assisted therapies into the mainstream of European healthcare. These therapies should be established as an additional option, accessible and affordable for all people, and recognized as registered and reimbursed medical treatments[2].
The values of PAREA are based on collaboration, transparency, and commitment to the common good. The name "PAREA" comes from Greek and stands for the shared experience and development in a circle of friends – a symbol of deep connection, the exchange of ideas, and community growth[2].
Sustainability Goals and Initiatives
PAREA is actively committed to a sustainable transformation of the European healthcare system. Key initiatives include:
- Promoting evidence-based information: Changing perceptions and strengthening social dialogue about psychedelic-assisted therapies.
- Scientific research: Supporting and accelerating EU-funded research to increase the clinical and scientific evidence for the safe use of these therapies.
- Regulatory harmonization: Advocating for a coherent and harmonized European policy and regulatory framework that ensures safe application and accessibility.
- Preparation of healthcare systems: Developing measures to improve the infrastructure and care standards for the introduction of psychedelic-assisted therapies[2][4].
Further relevant information
PAREA was officially founded on June 23, 2022. The organization is active as an actor at the European level and addresses its recommendations and appeals directly to political decision-makers, institutions, and professional societies. Core demands include the intensification of research funding, the expansion of clinical trials, and the creation of robust European standards for psychotherapeutic support and patient safety[4].
PAREA sees itself as a bridge builder between innovation, science, patient interests, and politics – with the aim of sustainably improving healthcare in Europe and increasing social acceptance of new therapeutic approaches.
